Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

DVAX 23.48 -0.10 (-0.42%)
price chart
7 Small Cap Stocks Holding Low Debt Ratios And Positive Analyst Ratings
Today we screened for smaller companies that have minimal debt, along with positive analyst ratings. When analysts on average favor a company, it signals that a company is doing a variety of things right for itself, which we think warrants further ...
Related articles »  
Hepatitis C Drug Companies and All-Oral Treatment: A $20 Billion Market
My main reason for thinking a sustainable stock rebound is possible was because it's a top-ten holding of value-investing legend Seth Klarman, who owns a 9.2% stake in the company (10 million shares) at an average purchase price of $8 per share (30% ...
Related articles »  
5 Pharmaceutical Companies With PDUFA Dates In Q1/2013
Zogenix (ZGNX) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.
Related articles »  
People Moves: September 2012
Dynavax announced the appointment of Christine Larson to the position of vice president and chief financial officer, a newly created position.
Interest Rates Going Nowhere, Home Depot CFO Says
Home Depot could issue another $2 billion in debt and still remain below its maximum desired leverage ratio, but Chief Financial Officer Carol Tome said interest rates won't be moving up from their near-historic lows anytime soon, so the company doesn ...